) mice spontaneously accumulate vast numbers of intestinal lamina propria (LP) T cells and develop bowel inflammation. The accumulation of T cells in IL2R␣
Ϫ/Ϫ mice is thought to result, in part, from defective Fas-induced cell death. To understand the role of cell proliferation and death in regulating LP T cells in IL2R␣
Ϫ/Ϫ mice, we have directly examined the proliferation and Fas sensitivity of wild-type, lpr/lpr, and IL2R␣
Ϫ/Ϫ LP T cells. In wild-type mice, 5Ј-bromodeoxyuridine (BrdU) labeling and Fas susceptibility are greatest in CD44
Hi LP T cells. Ϫ/Ϫ mice accumulate a large number of these Fas-sensitive LP T cells and clearly differ from Fasdeficient lpr/lpr mice in this regard. Thus our studies reveal that Fas is dispensable for LP T cell homeostasis and suggest that the intestinal inflammation observed in IL2R␣ Ϫ/Ϫ mice is independent of defective Fas-induced cell death. intestinal inflammation; colitis THE MAJORITY OF INTESTINAL lamina propria (LP) lymphocytes (LPLs) display markers consistent with prior activation (23, 34) . In addition to their phenotypic resemblance to activated lymphocytes, LPLs are functionally competent to perform effector functions such as cytolysis and cytokine elaboration (5, 12, 15, 16) . In this way, LPLs effectively monitor antigen presence in the intestine and regulate the duration and intensity of mucosal immune responses. The importance of properly regulating the number and activity of intestinal LP T cells is underscored by the fact that disturbances in the regulation of these cells are central to the pathogenesis of many animal models of spontaneous bowel inflammation (9, 21, 30) . These cells are likely to be important in the pathogenesis of human inflammatory bowel disease (IBD) as well. Thus understanding the signals that regulate LPL activation, cycling, survival, and differentiation into effectors is paramount to understanding the regulation of mucosal immunity.
One of the most potent regulators of LP T cells in vivo is the cytokine IL-2. Spontaneous bowel inflammation occurs in both IL-2-deficient (IL-2 Ϫ/Ϫ ) and IL-2 receptor ␣-deficient (IL-2R␣ Ϫ/Ϫ ) mice, indicating that IL-2 signals mediated through IL-2R␣ are critical for downregulating these cells in vivo (26, 33) . The inflammation in IL-2 Ϫ/Ϫ mice is a T cell-dependent process (20) and depends on IL-12-mediated Th1 type cytokines (10) . Moreover, several studies (14, 19, 22) have suggested that IL-2 Ϫ/Ϫ T cells may not differentiate into cells that are fully susceptible to Fas-mediated programmed cell death (PCD). IL-2-induced T cell activation and proliferation may increase T cell expression of Fas ligand (FasL) and suppress expression of c-FLIP, an inhibitor of Fas receptor signals (24) . Together, these studies suggest that the accumulation of activated T cells, which occurs in the absence of IL-2R␣ signals, is associated with muted induction of FasL expression and a relatively Fas-resistant state of activated T cells, at least compared with activated peripheral lymph node T cells in normal mice.
Although IL-2 receptor signals are likely associated with Fas sensitivity of activated T cells, it remains unclear whether IL-2 and Fas receptors play the same roles in regulating PCD of LP T cells as they do in regulating peripheral lymph node (PLN) T cells. Although Fas has been suggested to play an important role in regulating the numbers of activated LPLs (2), the progressive accumulation of activated T cells (including stereotypical CD3 ϩ B220 ϩ T cells) seen in peripheral lymph nodes and spleens of Fas-deficient lpr/lpr mrl mice is not seen in intestines of these mice (1). Moreover, Fas-deficient lpr/lpr mrl mice are not known to develop bowel inflammation similar to IL-2 Ϫ/Ϫ and IL-2R␣ Ϫ/Ϫ mice. Hence, the Fas receptor may play distinct roles from IL-2R in regulating the homeostasis of LP T cells.
To better understand the roles of Fas and IL-2 receptors in regulating LP T cells in vivo, we have used in vivo 5Ј-bromodeoxyuridine (BrdU) labeling to identify LP T cells that have passed through the S phase of the cell cycle. We have investigated the role of Fas-mediated PCD in regulating the homeostasis of these cells by studying the expression and functional competency of FasL/Fas signaling in normal LP T cells and by assessing cycling of LP T cells in lpr/lpr mice. Moreover, we have compared the homeostasis of LPL T cells in lpr/lpr vs. IL-2R␣ Ϫ/Ϫ mice (all on an inbred C57Bl/6J background) and studied the ability of IL-2R␣ Ϫ/Ϫ LPLs to respond to Fas signals. Our studies reveal novel insights into the homeostatic regulation of intestinal T cells, including critical distinctions between the roles of Fas and IL-2R signals in regulating these cells.
MATERIALS AND METHODS

Animals. Wild-type, IL-2R␣
Ϫ/Ϫ , and Fas-deficient lpr/lpr mice, all on a C57BL/6J background, were purchased from the Jackson Laboratory (Bar Harbor, ME) and were maintained in the University of Chicago animal facility under specific pathogen-free conditions.
Histology. Intestinal specimens were excised, fixed in buffered formalin, embedded in paraffin, and stained with hematoxylin and eosin. Inflammation was scored as described (7) in the proximate, mid-, and distal colon as follows: 1) leukocytic infiltration of the colon (0-3); 2) mucin depletion (0-2); 3) crypt abscesses (0-2); 4) epithelial erosion (0-2); 5) hyperemia (0-2); 6) mucosal thickness (1) (2) (3) , and the average of the three sections was obtained. The index of the severity of disease ranged from 1 (no disease) to 15 (severe disease). All specimens were denoted, coded, and examined by the same person on 1 day to prevent observer biases.
Lymphocyte collection. LPL and PLN T cells were collected as described (20) . Briefly, intestines were excised, cleared of adhering fat, and flushed with sodium bicarbonate free RPMI [supplemented with 10% FCS, ␤-mercaptoethanol, penicillin, and streptomycin (RPMI)]. Minced pieces of this intestine were then shaken in serum-free RPMI containing 1 mM EDTA to remove epithelial cells, washed, and then incubated (37°C, 30 min) in RPMI with 1 mg/ml collagenase B (Boerhinger Mannheim) and 0.25 mg/ml deoxyribonuclease I (Sigma) in a rotary shaker. Pooled LPL from two sequential enzymatic digestions were collected, layered over a discontinuous gradient of 44 and 70% Percoll, and centrifuged at 800 g for 20 min. Lymphocyte-enriched fractions were collected at the interface between 44 and 70% Percoll. The enzymes used for isolating LPL did not affect the expression of any lymphocyte surface markers used in this study. Resting T lymphocytes were obtained by magnetic bead depletion of activated lymphocytes using anti-CD44 MAb (PharMingen, San Diego, CA) and sheep anti-mouse IgG-coated Dynabeads M-450 (Dynal, Oslo, Norway). Activated T lymphocytes were obtained by culturing PLN T cells for 24 h in the presence of ConA (5 g/ml), followed by 24 h in recombinant murine IL-2 (10 ng/ml; PharMingen).
Flow cytometric analysis of lymphocytes. Lymphocytes were incubated with FITC, phycoerythrin (PE), Cy-Chrome (CYC), or biotin-conjugated MAbs specific for murine CD3, CD4, CD8a, CD44, Fas (PharMingen) or FasL (kindly provided by J. Tschopp). Biotinylated MAbs were developed with CYC or allophycocyanin-conjugated streptavidin (PharMingen). Cells were analyzed with a FACScalibur flow cytometer using Cell Quest Software (Becton Dickinson, San Jose, CA).
FasL-mediated lymphocyte killing. Fas-induced killing of lymphocytes was assayed as described (8) . Briefly, lymphocytes were cultured on 3T3 fibroblasts expressing either murine FasL (FasL fibroblasts) or an empty PSR␣ vector (control fibroblasts) for 18 h, incubated with FITC-conjugated anti-Thy1.2 MAb with or without anti-CD44 MAb, resuspended in PBS containing propidium iodide (1.0 mg/ml), and analyzed by flow cytometry.
In vivo analysis of lymphocyte cell cycling. BrdU was introduced into mice by either twice-daily intraperitoneal injections (0.4 mg/injection) or by continuous feeding in drinking water (0.8 mg/ml) for 4 days. Lymphocyte cycling in vivo was determined by flow cytometric analysis of BrdU incorporation into T cells using modifications of previously described techniques (6, 32) . Briefly, freshly isolated lymphocytes were incubated with MAbs specific for lymphocyte surface antigens, fixed, treated with DNase I, incubated with FITCconjugated anti-BrdU antibody (20 l/ml; Becton Dickenson), and analyzed by flow cytometry. For some studies, mice were thymectomized and allowed to recover for 4 wk. Thymectomized mice were fed BrdU water for 10-12 days and analyzed as above or switched to fresh water and "chased" for the indicated number of days.
Statistics. All data are derived from at least three independent experiments and are shown as the means Ϯ SD. Where indicated, paired data sets were analyzed by Student's t-test. Groups of data were analyzed by ANOVA followed by post hoc Tukey's. In all cases, significance was inferred at P Ͻ 0.05.
RESULTS
Cycling of PLN and LP T lymphocytes.
LPLs are thought to proliferate poorly in vitro (15, 31) . However, in vitro studies may neglect factors that normally support the proliferation of cells in vivo (15) . Moreover, many LP T cells express high levels of the activation/ memory marker CD44, which has been associated with a higher rate of proliferation in PLN T cells in vivo (32) . We therefore determined the extent of T cell cycling in the lamina propria relative to the periphery. To detect cycling cells in vivo, we treated mice with BrdU for 4 days and then isolated and immunostained LP and PLN T cells. Flow cytometric analyses of these cells showed that the percentage of T lymphocytes that were BrdU ϩ was consistently higher in the LP T cell population than in the PLN population (10.1 Ϯ 3.2 vs. 3.7 Ϯ 1.1%; P Ͻ 0.001; Fig. 1A ). This was observed in mice fed BrdU water for a range of times from 2 to 5 days and was independent of the route of BrdU administration (feeding vs. twice-daily injections; data not shown). Consistent with prior work, the majority (70-80%) of LP T cells were CD44
Hi memory phenotype cells (Fig. 1B) . Tough and Sprent (32) demonstrated a correlation between activation state (CD44 surface expression) and cycling (BrdU incorporation) of PLN T cells. We therefore examined the relationship of CD44 expression to BrdU incorporation in LP T cells. The majority of the BrdU ϩ T cells in both the PLN and LPL compartments were CD44 Hi (Fig. 1B) . Further analysis of these populations revealed that a lower proportion of CD44 Hi LP T cells incorporated BrdU than CD44 although this amounted to many fewer cells in the PLN population because of a fewer number of CD44 Hi cells. Thymocytes incorporate BrdU at a high rate in vivo and, after several days of administration, begin to contribute significantly to the number of peripheral BrdU ϩ T cells (32) . We therefore studied T cell BrdU incorporation in thymectomized mice. After the recent thymic emigres were removed from the analysis, we administered BrdU for longer periods (10-12 days) to obtain higher proportions of BrdU ϩ cells. The percentage of BrdU ϩ T cells was again higher in LP T cells than in PLN T cells (32 Ϯ 5.4 vs. 16.6 Ϯ 4.8%; P Ͻ 0.05; Fig. 2A ). On cessation of BrdU administration to thymectomized mice, the percentage of BrdU ϩ T cells decreased in both the LPL and PLN compartments but at a faster rate in the LPL compartment (Fig. 2B) , consistent with a more rapid turnover of T cells in the LPL population. The rate at which the percentage of BrdU ϩ cells increases is the sum of their proliferation rate minus the death rate, whereas the rate of decay following cessation of BrdU treatment is sum of the death rate minus the proliferation rate of BrdU-labeled cells (4) . Because substantial proliferation is required to dilute BrdU to undetectable levels in a given cell (4), it is unlikely that proliferation of BrdU ϩ cells contributes to reduced percentages of BrdU ϩ cells in a population. Instead, the loss of BrdU ϩ reflects the loss of labeled cells from a population. Thus the LP T population contains significant numbers of cycling cells and is subject to negative homeostatic regulation to prevent T cell accumulation within this compartment.
Fas-mediated cell death in LP T lymphocytes. Because significant numbers of LP T cells are cycling in vivo, it is apparent that this population must be subject to negative homeostatic regulation. Because Fas-deficient mice accumulate T cells in the periphery but not in the lamina propria, we sought to determine whether LP T cells are insensitive to Fas-induced death or whether Fas-deficient LP T cells display reduced cycling in vivo. The latter possibility was considered in light of the observation that T cells deficient for the critical Fas death-signaling molecule FADD have defective proliferative responses to some stimuli (35) . The cell surface expression of Fas is increased on activated T lymphocytes and is thought to correlate with, but not ensure, their susceptibility to FasL-mediated death (19, 28) . Because the majority of intestinal T lymphocytes display markers consistent with activation, we compared the level of Fas expression on LP T cells with activated and resting peripheral lymphocytes (Fig. 3) . Intestinal T cells expressed elevated Fas levels, comparable with stimulated PLN T lymphocytes (Fig. 3A) . Because FasL is dynamically regulated during T cell activation and must engage Fas to induce Fas-mediated PCD (28), we examined the expression of FasL on LP T cells. FasL expression on LP T cells was negligible, comparable with resting PLN T cells, and far below the levels found on activated PLN T cells (Fig. 3B) . Thus LP T cells express high levels of Fas but not FasL.
Fas receptor is constitutively expressed and does not universally dictate sensitivity to Fas-mediated PCD. Instead, sensitivity to Fas changes during lymphocyte A: mice were thymectomized, allowed to recover for 4 wk, and then fed BrdU water for 10 days. T lymphocytes were analyzed as described in Fig. 1. PLN Ϫ/Ϫ and lpr/lpr mice that were all backcrossed to the C57Bl/6J background. Consistent with previous reports (26, 33) , IL-2R␣ Ϫ/Ϫ mice possessed 3-to 10-fold greater numbers of LP T cells than normal littermates or age-and sex-matched lpr/lpr C57BL/6J mice. We routinely recovered 1-2 ϫ 10 6 LPL from normal mouse colon preparations. Histologically, IL-2R␣ Ϫ/Ϫ mice displayed mucosal hypertrophy, crypt abscesses, goblet cell depletion, and edema that was scored as severe to very severe (Fig. 4) . These mice typically yielded 5-20 ϫ 10 6 LPL. There was no difference in the disease severity index between lpr/lpr and wild-type mice. Thus IL-2R, but not Fas, regulates inflammation and T cell number in the intestinal lamina propria.
To address how IL-2 deficiency perturbs LPL homeostasis, we administered BrdU to IL-2R␣ Ϫ/Ϫ and control mice for 4 days and studied BrdU incorporation of T cells. The proportion of BrdU ϩ CD4 ϩ T cells in IL-2R␣ Ϫ/Ϫ PLNs was increased substantially over normal (Table 2) . Although the absolute number of LP T cells was greater in IL-2R␣ Ϫ/Ϫ than in normal mice, the percentage of BrdU ϩ LP T cells was comparable between these strains of mice (Table 2) Values are means Ϯ SD. Mice were fed 5Ј-bromodeoxyuridine (BrdU) in drinking water for 3-4 days. of each group. * P Ͻ 0.05 vs. Normal.
IL-2R␣
Ϫ/Ϫ , IL-2 receptor ␣-deficient.
night. Comparable Fas-specific killing was observed in LP T cells freshly harvested from all strains (Table 1) . Thus IL-2R signals are not necessary for the acquisition of Fas sensitivity by LP T cells.
DISCUSSION
The inflammation that occurs in IL-2R␣ Ϫ/Ϫ mice is thought to be due, in part, to the reduced ability of IL-2R␣ Ϫ/Ϫ T cells to undergo Fas-induced cell death (24) . This relationship between IL-2 and Fas is supported by the observation that peripheral lymphadenopathy occurs in IL-2
Ϫ/Ϫ , and Fas-deficient mice. However, spontaneous IBD occurs in IL-2 Ϫ/Ϫ and IL-2R␣ Ϫ/Ϫ but not Fas-deficient mice. We therefore examined the possibility that Fas and/or IL-2 play roles in the homeostatic regulation of LP T cells that are distinct from their roles in peripheral T cell homeostasis. In this report, we show that although LP T cells are Fas sensitive, Fas signals contribute only minimally to their basal homeostatic regulation, possibly because of a paucity of FasL expression in activated LP T cells. We also show that LP T cells are cycling in lpr/lpr mice and also in IL-2R␣
Ϫ/Ϫ mice but that these cells accumulate only in the intestinal lamina propria of the latter. Finally, we demonstrate that FasL sensitivity is not diminished in IL-2R␣ Ϫ/Ϫ LP T cells, suggesting that the accumulation of T lymphocytes in IL-2 Ϫ/Ϫ animals is not due to a diminution of their sensitivity to Fas killing.
Our data showing that the intestinal LP T cell population includes a significant proportion of cycling cells that rapidly turn over in vivo suggest that this population must be subject to negative homeostatic regulation, because the size of the LP compartment remains relatively constant. We therefore investigated the possible role of Fas-mediated cell death as a mechanism for negative homeostatic regulation of LP T cells. Although LP T cells expressed high levels of Fas and were sensitive to FasL-induced killing ex vivo, there was no increase in the number of LPLs of lpr/lpr mice compared with littermate controls in the same genetic background. This confirms prior studies showing no intestinal inflammation in lpr/lpr mrl mice (1). Unlike activated peripheral T cells, the activated T cells of the gut do not display increased FasL expression. Thus Fas may not play significant a role in intestinal T cell homeostasis because LP T cells do not upregulate FasL. To dispel the possibility that lpr/lpr LPLs do not accumulate owing to a lack of cycling in the gut, we demonstrated that these cells indeed do incorporate BrdU in vivo and that the rate of cycling was somewhat higher than that of control littermates. The slightly higher percentage of BrdU ϩ cells seen in lpr/lpr LP T cells suggests that Fas deficiency allows a greater proportion of proliferating LP T cells to survive in vivo, even in the C57BL/6J background. However, the maintenance of normal LP T cell numbers in lpr/lpr mice argues that alternative cell death mechanisms compensate for the absence of Fas-mediated PCD in these mice. Such pathways may include those mediated by Ϫ/Ϫ mice. In addition, we observed a higher rate of BrdU incorporation in the PLN of IL-2R␣ Ϫ/Ϫ mice and cannot discount the possibility that the increased cell numbers in the LP of these mice was a consequence of the peripheral expansion and recruitment of T cells into the gut. In either case, novel IL-2-dependent death molecules that regulate the LP T cell population may yet be discovered.
In addition, the role of regulatory cells in IBD has recently received renewed interest (13, 29) . One such population, identified phenotypically as CD4ϩ CD25ϩ regulatory cells, has been implicated in the SCID transfer model of colitis. These CD25ϩ cells produce significant immunoregulatory transforming growth factor-␤ (TGF-␤) and can prevent colitis in some models of IBD (30) . Mice with targeted disruption of TGF-␤ signaling in T cells develop intestinal inflammation (17, 27) . Significantly, Ehrhardt et al. (10) showed that treatment of mice with colitis-inducing trinitrophenolkeyhole limpet hemocyanin causes significant TGF-␤ production in wild type but not IL-2 Ϫ/Ϫ mice. The absence of these TGF-␤-producing regulatory cells rather than defective Fas signaling may underlie the IBD seen in IL-2R␣ Ϫ/Ϫ mice.
